Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RevonBioFZ
Dubai, Dubai, United Arab Emiratesrevonbio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
RevonBio is a biotechnology company based in the Dubai Science Park, United Arab Emirates, focusing on the development and commercialization of innovative therapies. The company operates as a Free Zone Limited Liability Company (FZ-LLC) and aims to bridge the gap between global pharmaceutical innovation and regional healthcare needs in the Middle East and North Africa. RevonBio's primary focus areas include oncology, rare diseases, and infectious diseases, leveraging a network of global partnerships to advance its pipeline. The company is positioned as a regional hub for life sciences research and development, emphasizing the translation of scientific discoveries into clinical applications.
- Therapeutic areas
- Infectious DiseasesOncologyRare Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on RevonBioFZ.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RevonBioFZ.